Barriers and facilitators to implementing polypharmacy management frameworks: a theory based qualitative exploration of key stakeholders
Authors:
Open Access
- 12 December 2024
- journal article
- research article
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 47 (2) , 412-422
Abstract
Background: Inappropriate polypharmacy arises through many factors including deficiencies in prescribing processes. Most research has focused on solutions at the clinician/patient levels with less at the organisational level. Aim: To explore key stakeholder identified barriers and facilitators to implementation of an organisational level polypharmacy management framework. Method: Qualitative data were collected within the Ministry of Health in Oman. Key stakeholders were purposively sampled encompassing senior representatives of pharmacy, medicine, and nursing directors; healthcare policymakers; patient safety leaders; and academic leaders. A semi-structured interview schedule was developed informed by a recent scoping review and underpinned by the Consolidated Framework for Implementation Research (CFIR). Interviews, which continued until data saturation, were audio-recorded, transcribed and analysed using the Framework Approach. Results: Thirteen key stakeholders were interviewed, with representation of each target group. Facilitators largely mapped to the CFIR domain of inner setting (i.e., aspects of stakeholder awareness, the electronic health system and national leadership), intervention characteristic (evidence gaps), characteristics of individuals (stakeholders and champions) and process (change strategy). Barriers also largely mapped to the inner setting (policy absence, communication and health professional practice) and outer setting (resource needs). Conclusion: This study has illuminated the facilitators and barriers to the implementation of an organisational level polypharmacy management framework. Further work is required to translate these themes into an actionable plan to implement the framework. Particular attention is required for aspects of the CFIR domain of inner setting (i.e., the internal context within which implementation occurs) as most barriers mapped to this domain.Keywords
This publication has 58 references indexed in Scilit:
- Application of behavioural theories, models, and frameworks in pharmacy practice research based on published evidence: a scoping reviewInternational Journal of Clinical Pharmacy, 2024
- Implementation frameworks for polypharmacy management within healthcare organisations: a scoping reviewInternational Journal of Clinical Pharmacy, 2023
- Medication review in hospitalised patients to reduce morbidity and mortalityCochrane Database of Systematic Reviews, 2023
- A qualitative exploration of factors contributing to non-guideline adherent antipsychotic polypharmacyResearch in Social and Administrative Pharmacy, 2022
- Polypharmacy in elderly peopleWiener Medizinische Wochenschrift, 2022
- Adverse Outcomes of Polypharmacy in Older People: Systematic Review of ReviewsJournal of the American Medical Directors Association, 2020
- The polypharmacy programme in Scotland: realistic prescribingPrescriber, 2019
- Interventions to improve the appropriate use of polypharmacy for older peopleCochrane Database of Systematic Reviews, 2018
- Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional studyThe Lancet, 2012
- Polypharmacy in nursing home residents in the United States: Results of the 2004 National Nursing Home SurveyThe American Journal of Geriatric Pharmacotherapy, 2010